HLX07(Anti-EGFR mAb) in Patients With Advanced or Metastatic Solid Tumors
Clinical trial NCT05360368 · UNKNOWN
Trial details
- NCT number
- NCT05360368
- Sponsor
- Shanghai Henlius Biotech
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-30
- Primary completion
- 2023-12-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.